Apple to roll out hypertension detection on smart watch after FDA nod
Feature will be available on Apple Watch Series 9, Series 10, Series 11, and Ultra 2 and Ultra 3 smartwatches
Apple is set to unveil the latest hypertension detection feature in its smartwatch by next week, after Food and Drug Administration (FDA) clearance on Thursday, Bloomberg News reported.
Apple and the FDA did not immediately respond to Reuters' requests for comment.
The company unveiled a blood pressure monitor in its latest Apple Watch at the September 9 event, where it also introduced a refreshed iPhone lineup, including a slimmer iPhone Air.
The feature, pending regulatory approval, will not detect every case of high blood pressure, but could alert about a million people, Apple said.
Available in 150 countries, the tool will use data from the watch's optical heart sensor to track how a user's blood vessels respond to heartbeats over 30 days, the report said, citing Apple.
The feature will be available on the Apple Watch Series 9, Series 10, Series 11, and its more expensive Ultra 2 and Ultra 3 smartwatches, Bloomberg News said.
-
Aurora alert: Northern lights visible tonight at high latitudes -
Honeybees could help humans communicate with aliens, scientists say -
Comet 3I/ATLAS: Evidence suggests that interstellar visitor is older than the sun -
Scientists discovered never-before-seen creature in Great Salt Lake -
SpaceX mission 2026: 29 Starlink satellites deployed in year’s third flight -
NASA, SpaceX announce target date for Crew-11’s splashdown return to Earth -
World oceans absorbed record heat in 2025, may trigger intense climate crises, says report -
February full moon 2026: Snow Moon date, time and visibility